Health and Fitness Health and Fitness
Wed, September 14, 2011
[ Wed, Sep 14th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at UBS Global Life Sciences Conference on September 21st
Tue, September 13, 2011
[ Tue, Sep 13th 2011 ] - Market Wire
InterMune Announces Pricing of Concurrent Public .. of Common Stock and $135 Million Principal Amoun
[ Tue, Sep 13th 2011 ] - Market Wire
Transcept Pharmaceuticals Announces FDA Response .. l in Support of Intermezzo® New Drug Application
[ Tue, Sep 13th 2011 ] - Market Wire
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
[ Tue, Sep 13th 2011 ] - Market Wire
Nordion Inc. Declares Quarterly Dividend
[ Tue, Sep 13th 2011 ] - Market Wire
Nordion Reports Third Quarter 2011 Financial Results
[ Tue, Sep 13th 2011 ] - Market Wire
Merck Statement on GARDASIL®
[ Tue, Sep 13th 2011 ] - Market Wire
Cambridge Heart Expands Distribution into Latin America
[ Tue, Sep 13th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. ation at Bank of America Merrill Lynch Conference
[ Tue, Sep 13th 2011 ] - Market Wire
HCA Appoints Dr. Michael Cuffe President and CEO of Physician Services for HCA
[ Tue, Sep 13th 2011 ] - Market Wire
iCo Therapeutics CEO to Present &;; Act as .. nnual Drug Repositioning and Pipeline Enhancement
[ Tue, Sep 13th 2011 ] - Market Wire
Wellmark,;; Healthways and Governor Bra .. e Zones Projecta" to Improve Well-Being of Iowans
[ Tue, Sep 13th 2011 ] - Market Wire
Teva Announces Additional Investment in CureTech
[ Tue, Sep 13th 2011 ] - Market Wire
Merck Partners with Susan G. Komen for the Cure® .. p Address Cervical and Breast Cancer in Developin
[ Tue, Sep 13th 2011 ] - Market Wire
LabCorp';s Zero Coupon Convertible Su .. ated Notes Due 2021 to Accrue Contingent Interest
[ Tue, Sep 13th 2011 ] - Market Wire
IDC appoints new Chairman to Board of Directors
[ Tue, Sep 13th 2011 ] - Market Wire
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen,;; Inc.
[ Tue, Sep 13th 2011 ] - Market Wire
AMRI CFO to Present at UBS Global Life Sciences Conference
[ Tue, Sep 13th 2011 ] - Market Wire
BioLineRx Announces Positive Preliminary Results .. I Clinical Trial of BL-1021 for Neuropathic Pain
[ Tue, Sep 13th 2011 ] - Market Wire
Seattle Genetics and Oxford BioTherapeutics to Collaborate on Antibody-Drug Conjugates for Cancer
[ Tue, Sep 13th 2011 ] - Market Wire
Compugen Announces Validation of Two Immune System Modulating Drug Candidates
Mon, September 12, 2011
[ Mon, Sep 12th 2011 ] - Market Wire
Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies
[ Mon, Sep 12th 2011 ] - Market Wire
Centre Hospitalier de Chaumont in Frankreich fhrt .. hungssystem fr eine grere Patientensicherheit ein
[ Mon, Sep 12th 2011 ] - Market Wire
HeartWare schliet GLP-Studien fr MVAD®-Pumpe der .. ; Daten heute beim ISRBP-Kongress vorgestellt
[ Mon, Sep 12th 2011 ] - Market Wire
Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
[ Mon, Sep 12th 2011 ] - Market Wire
InterMune Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Debt
[ Mon, Sep 12th 2011 ] - Market Wire
Neuralstem President and CEO to Update Ongoing AL .. 011 Rodman & Renshaw Annual Healthcare Conference
[ Mon, Sep 12th 2011 ] - Market Wire
Gallup and Healthways Release August 2011 Well-Being Index
[ Mon, Sep 12th 2011 ] - Market Wire
Impax Laboratories Confirms Patent Challenge Relating to Generic JALYN® 0.5 mg/0.4 mg
[ Mon, Sep 12th 2011 ] - Market Wire
Array BioPharma to Present at the UBS Global Life Sciences Conference

Array BioPharma to Present at the UBS Global Life Sciences Conference


Published on 2011-09-12 14:46:29 - Market Wire
  Print publication without navigation


BOULDER, Colo.--([ BUSINESS WIRE ])--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Global Life Sciences Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event: UBS Global Life Sciences Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Monday, September 19, 2011
Time: 10:00 a.m. Eastern Time
Location: The Grand Hyatt New York, NY
Webcast:[ www.arraybiopharma.com ]

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to [ www.arraybiopharma.com ].

Contributing Sources